Zydus Lifesciences (ZYDUSLIFE) — Announcement

1 Announcement Neutral 📄 PDF

📢 Key Event
Zydus launches India's first nebulised LAMA for COPD

💡 Investor Takeaway
This introduces a novel COPD therapy with potential for market share gains in a large patient population.

Zydus Lifesciences announced the launch of REVAHALE™, India's first once-daily nebulised LAMA for COPD maintenance treatment, offering sustained 24-hour bronchodilation via jet nebuliser delivery. The therapy addresses unmet needs in COPD management, particularly for elderly and severely impaired patients who struggle with handheld inhalers, providing a differentiated option with potential for broader patient adoption.

2 Announcement Neutral 📄 PDF

📢 Key Event
Zydus Lifesciences to attend Motilal Oswal investor conference

💡 Investor Takeaway
Investors can expect management updates at the upcoming conference.

Zydus Lifesciences announced its participation in the Motilal Oswal 22nd Annual Global Investor Conference on August 18, 2026, inviting investors to attend the event and highlighting its ongoing engagement with institutional stakeholders.

📊 Stock Analysis — ZYDUSLIFE ✨ Ask AI About This

About Zydus Lifesciences Limited (ZYDUSLIFE)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹1,01,800.69 Cr P/E: 22.5

View full ZYDUSLIFE stock details →

📡 Get AI alerts when ZYDUSLIFE files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track ZYDUSLIFE — Free

💡 Ask AI about this filing

"How will pricing compare to existing COPD inhalers?" "What is the projected revenue contribution from REVAHALE™?" "When will REVAHALE™ be available commercially?"

Ask AI Free →

📊 More ZYDUSLIFE filings

See all ZYDUSLIFE filings →

🔥 Also filed on 10 August 2026

TIMKEN Timken India Limited Financial Results AMJLAND Amj Land Holdings Limited Annual Report DOMS DOMS Industries Limited Corporate Action HGS Hinduja Global Solutions Limited Financial Results SUNDRMFAST Sundram Fasteners Limited Financial Results KANSAINER Kansai Nerolac Paints Limited Financial Results

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when ZYDUSLIFE files new disclosures

Track ZYDUSLIFE filings, board meetings, and corporate actions. Free email alerts at 5 PM.